Evidence map›Paper›PMID 36091689›Full record

SynthesisFrontiers in medicine2022

A systematic review on time trend incidence of rheumatoid arthritis in outpatient rheumatology clinics.

E T A M van Delft, Maha Jamal, Hannah den Braanker, T M Kuijper, J M W Hazes, Deirisa Lopes Barreto, A E A M Weel-Koenders

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

E T A M van DelftDepartment of Rheumatology, Maasstad Hospital, Rotterdam, Netherlands.
Maha JamalDepartment of Rheumatology, Maasstad Hospital, Rotterdam, Netherlands.
Hannah den BraankerDepartment of Rheumatology, Maasstad Hospital, Rotterdam, Netherlands.
T M KuijperDepartment of Rheumatology, Maasstad Hospital, Rotterdam, Netherlands.
J M W HazesDepartment of Rheumatology, Erasmus Medical Centre, Rotterdam, Netherlands.
Deirisa Lopes BarretoDepartment of Rheumatology, Maasstad Hospital, Rotterdam, Netherlands.
A E A M Weel-KoendersDepartment of Rheumatology, Maasstad Hospital, Rotterdam, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To classify patients with rheumatoid arthritis (RA) in an earlier stage of the disease, the ACR/EULAR classification criteria were updated in 2010. These criteria might have led to an increased incidence of RA in the rheumatology clinic. Since a higher incidence increases the socio-economic burden of RA, it is worthwhile to evaluate whether there is a time effect. Materials and methods: A systematic review was conducted using Embase, Medline Ovid, Cochrane Central, and Web of Science from database inception to February 2021. Included were only articles that addressed incidence rates of rheumatoid arthritis from rheumatology outpatient clinics. Results: Of the 6,289 publications only 243 publications on RA were found eligible for full-text review. Nine studies were included reporting incidence. The pooled incidence for RA was 11% (95% CI 6-16%) per year. Over time the incidence increased after the introduction of the 2010 ACR/EULAR classification criteria. Overall there was a high intragroup heterogeneity ( Conclusion: Although the incidence seems to increase after the introduction of the 2010 ACR/EULAR criteria, no conclusions can be drawn on this time effect due to heterogeneity.

Indexed as

incidencemusculoskeletal complaintsoutpatientreferralrheumatoid arthritis

Identifiers

PMID36091689
PMCPMC9448917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.